The (Re)-emerging And ePidemic Infectious Diseases (RAPID) Stigma Scales: a cross-outbreak scale development and pyschometric validation study.
Paterson A. et al, (2025), Lancet Infect Dis
Adaptive Design for Phase II/III Platform Trial of Lassa Fever Therapeutics.
Bourner J. et al, (2025), Emerg Infect Dis, 31, 9 - 16
Improving clinical care of patients in Nipah outbreaks: moving beyond 'compassionate use'.
Hassan MZ. et al, (2025), Lancet Reg Health Southeast Asia, 33
Clinical characterisation and outcomes of human clade IIb mpox virus disease - a European multicentre observational cohort study (MOSAIC).
Pesonel E. et al, (2025), Clin Infect Dis
The priority review voucher: a misconceived quid pro quo.
Olliaro P. and Torreele E., (2024), BMJ Glob Health, 9
Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials.
Chan XHS. et al, (2024), Lancet Microbe
PP290 Topic: AS03–Disaster Medicine/Trauma, Triage and Transport/Mass Critical Care/Pandemics/Medicine in War Zones/Other: CLINICAL CHARACTERISTICS AND HEALTH OUTCOMES FOR CHILDREN HOSPITALIZED WITH COVID-19
Appiah JA. et al, (2024), Pediatric Critical Care Medicine, 25
Cost-Effectiveness of Test-and-Treat Strategies to Reduce the Antibiotic Prescription Rate for Acute Febrile Illness in Primary Healthcare Clinics in Africa.
van Dorst PWM. et al, (2024), Appl Health Econ Health Policy, 22, 701 - 715
Impact of a package of point-of-care diagnostic tests, a clinical diagnostic algorithm and adherence training on antibiotic prescriptions for the management of non-severe acute febrile illness in primary health facilities during the COVID-19 pandemic in Burkina Faso.
Kiemde F. et al, (2024), BMC Infect Dis, 24
An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial-an update to the published protocol.
Randremanana RV. et al, (2024), Trials, 25
Challenges in clinical diagnosis of Clade I Mpox: Highlighting the need for enhanced diagnostic approaches.
Bourner J. et al, (2024), PLoS Negl Trop Dis, 18
The facilitators of and barriers to antimicrobial use and misuse in Lalitpur, Nepal: a qualitative study.
Udas S. et al, (2024), BMC Public Health, 24
Interpretations of Studies on SARS-CoV-2 Vaccination and Post-acute COVID-19 Sequelae.
Gonçalves BP. et al, (2024), Epidemiology, 35, 368 - 371
Diagnostic tests for human Schistosoma mansoni and Schistosoma haematobium infection: a systematic review and meta-analysis.
Vaillant MT. et al, (2024), Lancet Microbe, 5, e366 - e378
Nipah Virus Therapeutics: A Systematic Review to Support Prioritisation for Clinical Trials
Chan XHS. et al, (2024)
Systematic Review of Scales for Measuring Infectious Disease-Related Stigma.
Paterson A. et al, (2024), Emerg Infect Dis, 30, 519 - 529
Involving patients in drug development for Neglected Tropical Diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis into Target Product Profile development
Castro MDM. et al, (2024), PLoS Neglected Tropical Diseases, 2024